Aktuellt
SENASTE
Although continued Covid-19 related uncertainties prevail and expanded opex clouds the near term, we expect Bactiguard to gradually improve during the year. Over the long term, we see several growth engines for Bactiguard’s current platform, including implants sales with ZB, broader distribution of wound care products and deeper market penetration of its coated catheters. Further future new licence deals are an option on top.
LÄS MER
